| |
Hensley, S., Vranica, S., Wilde-Matthews, A. (2005, February 22) Merck, Pfizer Face Advertising Obstacle;If Vioxx, Celebrex Return, The Drugs Promotion Will Be a Difficult Task. The Wall Street Journal, p. B3
VIOXX Crisis
Hensley, S., Vranica, S., Wilde-Matthews, A. (2005, February 22) Merck, Pfizer Face Advertising Obstacle;If Vioxx, Celebrex Return, The Drugs Promotion Will Be a Difficult Task. The Wall Street Journal, p. B3
Crisis Communication in Public Relations
Hensley, S., Vranica, S., & Mathews, A.W. (2005, February 22). Merck, Pfizer face advertising obstacle. The Wall Street Journal, p. B3.
Pharmaceutical Public Relations
Pfizer. 2004. Pfizer. 6 Dec. 2004 <http://www.pfizer.com>
Pfizer, Inc. and the Pharmaceutical Industry
Merck Manual of Diagnosis and Therapy, Sixteenth Edition, ed. Robert Berkow, Merck Research Laboratories, Merck & Co., Inc., New Jersey, 1992.
Necrotizing Fasciitis
|
|
